Literature DB >> 15452265

Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1.

Robert J Hogan1, Guangping Gao, Thomas Rowe, Peter Bell, Douglas Flieder, Jason Paragas, Gary P Kobinger, Nelson A Wivel, Ronald G Crystal, Julie Boyer, Heinz Feldmann, Thomas G Voss, James M Wilson.   

Abstract

Intranasal inhalation of the severe acute respiratory syndrome coronavirus (SARS CoV) in the immunocompetent mouse strain 129SvEv resulted in infection of conducting airway epithelial cells followed by rapid clearance of virus from the lungs and the development of self-limited bronchiolitis. Animals resistant to the effects of interferons by virtue of a deficiency in Stat1 demonstrated a markedly different course following intranasal inhalation of SARS CoV, one characterized by replication of virus in lungs and progressively worsening pulmonary disease with inflammation of small airways and alveoli and systemic spread of the virus to livers and spleens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452265      PMCID: PMC521834          DOI: 10.1128/JVI.78.20.11416-11421.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Mechanisms and enzymes involved in SARS coronavirus genome expression.

Authors:  Volker Thiel; Konstantin A Ivanov; Ákos Putics; Tobias Hertzig; Barbara Schelle; Sonja Bayer; Benedikt Weißbrich; Eric J Snijder; Holger Rabenau; Hans Wilhelm Doerr; Alexander E Gorbalenya; John Ziebuhr
Journal:  J Gen Virol       Date:  2003-09       Impact factor: 3.891

2.  Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS).

Authors:  G M-K Tse; K-F To; P K-S Chan; A W I Lo; K-C Ng; A Wu; N Lee; H-C Wong; S-M Mak; K-F Chan; D S C Hui; J J-Y Sung; H-K Ng
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

3.  Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice.

Authors:  Kanta Subbarao; Josephine McAuliffe; Leatrice Vogel; Gary Fahle; Steven Fischer; Kathleen Tatti; Michelle Packard; Wun-Ju Shieh; Sherif Zaki; Brian Murphy
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

4.  Sorting of progeny coronavirus from condensed secretory proteins at the exit from the trans-Golgi network of AtT20 cells.

Authors:  J Tooze; S A Tooze; S D Fuller
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

5.  Interferon-beta 1a and SARS coronavirus replication.

Authors:  Lisa E Hensley; Lisa E Fritz; Peter B Jahrling; Christopher L Karp; John W Huggins; Thomas W Geisbert
Journal:  Emerg Infect Dis       Date:  2004-02       Impact factor: 6.883

6.  Characterization of the budding compartment of mouse hepatitis virus: evidence that transport from the RER to the Golgi complex requires only one vesicular transport step.

Authors:  J Krijnse-Locker; M Ericsson; P J Rottier; G Griffiths
Journal:  J Cell Biol       Date:  1994-01       Impact factor: 10.539

7.  A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice.

Authors:  Zhi-Yong Yang; Wing-Pui Kong; Yue Huang; Anjeanette Roberts; Brian R Murphy; Kanta Subbarao; Gary J Nabel
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

8.  The clinical pathology of severe acute respiratory syndrome (SARS): a report from China.

Authors:  Yanqing Ding; Huijun Wang; Hong Shen; Zhuguo Li; Jian Geng; Huixia Han; Junjie Cai; Xin Li; Wei Kang; Desheng Weng; Yaodan Lu; Dehua Wu; Li He; Kaitai Yao
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

9.  Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

Authors:  Bart L Haagmans; Thijs Kuiken; Byron E Martina; Ron A M Fouchier; Guus F Rimmelzwaan; Geert van Amerongen; Debby van Riel; Ton de Jong; Shigeyuki Itamura; Kwok-Hung Chan; Masato Tashiro; Albert D M E Osterhaus
Journal:  Nat Med       Date:  2004-02-22       Impact factor: 53.440

10.  The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein.

Authors:  Martin Spiegel; Andreas Pichlmair; Elke Mühlberger; Otto Haller; Friedemann Weber
Journal:  J Clin Virol       Date:  2004-07       Impact factor: 3.168

View more
  77 in total

1.  Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections.

Authors:  Markus Mordstein; Eva Neugebauer; Vanessa Ditt; Birthe Jessen; Toni Rieger; Valeria Falcone; Frederic Sorgeloos; Stephan Ehl; Daniel Mayer; Georg Kochs; Martin Schwemmle; Stephan Günther; Christian Drosten; Thomas Michiels; Peter Staeheli
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

2.  Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus.

Authors:  Tracey Baas; Anjeanette Roberts; Thomas H Teal; Leatrice Vogel; Jun Chen; Terrence M Tumpey; Michael G Katze; Kanta Subbarao
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

3.  Application of siRNA against SARS in the rhesus macaque model.

Authors:  Qingquan Tang; Baojian Li; Martin Woodle; Patrick Y Lu
Journal:  Methods Mol Biol       Date:  2008

4.  Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak/STAT signaling.

Authors:  Rebeca Burdeinick-Kerr; Dhanasekaran Govindarajan; Diane E Griffin
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

5.  Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain.

Authors:  Marc G Wathelet; Melissa Orr; Matthew B Frieman; Ralph S Baric
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

6.  Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection.

Authors:  Jun Chen; Yuk Fai Lau; Elaine W Lamirande; Christopher D Paddock; Jeanine H Bartlett; Sherif R Zaki; Kanta Subbarao
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

7.  SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.

Authors:  Matthew B Frieman; Jun Chen; Thomas E Morrison; Alan Whitmore; William Funkhouser; Jerrold M Ward; Elaine W Lamirande; Anjeanette Roberts; Mark Heise; Kanta Subbarao; Ralph S Baric
Journal:  PLoS Pathog       Date:  2010-04-08       Impact factor: 6.823

8.  Unraveling the complexities of the interferon response during SARS-CoV infection.

Authors:  Anna de Lang; Tracey Baas; Saskia L Smits; Michael G Katze; Albert Dme Osterhaus; Bart L Haagmans
Journal:  Future Virol       Date:  2009-01-01       Impact factor: 1.831

9.  Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.

Authors:  Luis Enjuanes; Marta L Dediego; Enrique Alvarez; Damon Deming; Tim Sheahan; Ralph Baric
Journal:  Virus Res       Date:  2007-04-09       Impact factor: 3.303

10.  The SARS-CoV ferret model in an infection-challenge study.

Authors:  Yong-Kyu Chu; Georgia D Ali; Fuli Jia; Qianjun Li; David Kelvin; Ronald C Couch; Kevin S Harrod; Julie A Hutt; Cheryl Cameron; Susan R Weiss; Colleen B Jonsson
Journal:  Virology       Date:  2008-01-29       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.